Last reviewed · How we verify

qIRV — Competitive Intelligence Brief

qIRV (qirv) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Not specified. Area: Infectious Disease.

marketed Not specified Not specified Infectious Disease Vaccine Live · refreshed every 30 min

Target snapshot

qIRV (qirv) — Pfizer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
qIRV TARGET qirv Pfizer marketed Not specified Not specified
Plegisol In Plastic Container Sodium Chloride Baxter marketed Electrolyte solution Not specified 1965-01-01
Plegisol In Plastic Container Sodium Chloride Baxter marketed Electrolyte solution Not specified 1965-01-01
Tumor Tissue tumor-tissue Pfizer marketed Not specified Not specified
Pf-07832837 pf-07832837 Pfizer marketed Small molecule Not specified
Various various Pfizer marketed Antibiotic Not specified
Met097 met097 Pfizer marketed Not specified Not specified

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Not specified class)

  1. Pfizer · 17 drugs in this class
  2. BioNTech · 1 drug in this class
  3. Novartis Pharmaceuticals · 1 drug in this class
  4. Pfizer Inc. · 1 drug in this class
  5. Vaxxinity, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). qIRV — Competitive Intelligence Brief. https://druglandscape.com/ci/qirv. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: